Skip to main content
. 2014 May 6;14(2):113–123. doi: 10.1007/s40268-014-0045-9

Table 6.

Final multiple linear regression model for z-scores of log-transformed dabigatrantrough (n = 52)

Predictora B SE (B) p Value
Constant 3.99 1.08 0.001
CKD-EPI_CrCysb −0.69 0.09 <0.001
Time between last dose and sample −0.09 0.06 0.11
Phenytoin and phenobarbitone −2.62 0.65 <0.001
Proton-pump inhibitor −0.55 0.22 0.017
Amiodarone and/or verapamil 0.35 0.23 0.13
rs2244613 0.18 0.47 0.70
rs4122228 −0.13 0.47 0.79
rs8192935 0.03 0.22 0.91

Unadjusted R 2 = 0.69

B unstandardised coefficients, SE standard error, CKD-EPI Chronic Kidney Disease Epidemiology Collaboration, Cr creatinine, Cys cystatin C

aFor all drugs, a value of 1 was assigned to those without the drug, and a value of 2 assigned to those on the drug. A value of 1 was assigned to patients who had a wildtype genotype. Patients who were heterozygous or homozygous for the single nucleotide polymorphism of interest were assigned a value of 2

bThe z-scores of the log-transformed CKD-EPI_CrCys values